glp-1 and lupus Weight Loss with Lupus: Safety Guide GLP-1RA Cuts Cardiovascular and Kidney

Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model

Published research describes the following mechanisms for MC1R agonists like afamelanotide: NF-kappaB suppression reduced transcription of pro-inflammatory genes Cytokine modulation decreased TNF-alpha, IL-1beta, and IL-6 production Nitric oxide regulation normalization of NO pathway signaling Adhesion molecule downregulation reduced inflammatory cell migration IL-10 upregulation increased anti-inflammatory cytokine output These effects have been demonstrated in vitro and in animal models of acute, chronic, and systemic inflammation (Catania et al., 2004)

On the other hand, some literature suggests that L-carnitine, by promoting pyruvate oxidation, may accelerate carbohydrate breakdown, leading to rapid depletion of muscle glycogen and potentially producing a detrimental effect on exercise performance

Extended data figures and tables Extended Data Fig

Also Read: GLP-1 drugs move beyond diabetes and weight loss to multi-organ protection (Edited by Sumavarsha)

Butyric acid is a short-chain fatty acid believed to provide optimal benefit to the gastrointestinal tract